Haggar Hilda Ampadu

Dr. Haggar Hilda Ampadu
Born
Eastern Region Ghana
Occupations
  • Research scientist
  • Policist
Years active2002–present

Haggar Hilda Ampadu is a Ghanaian regulator, pharmacoepidemiologist (research scientist) and policy advocate.[1][2] As of 2019, she is the Inspector-General of Schools of the National Schools Inspectorate Authority under Ghana's Ministry of Education.

Early life

Hilda was born at the Kwahu Tafo Government Hospital to Charles Ampadu and Mary Ampadu of Kwahu Nteso in the Eastern Region.[3] She is married with two children.

Education

She attended Harrow International School in Abeka Lapaz, where she stayed from kindergarten through her Junior High School.[1]

She attended Wesley Girls’ High School and graduated in 1995.[3]

Hilda progressed to the Kwame Nkrumah University of Science and Technology (KNUST) in 1997 to pursue a BSc Biological Science and later moved to United States in 2001 where she graduated with MSc Project Management from Boston University in 2011.

Hilda read her PhD in Pharmaceutical Policy & Regulation at the Utrecht University in the Netherlands, graduating in 2018.[4][5]

Career

In 2002, she started as a Clinical Data Manager (Consultant) for GSK's Diabetes Clinical Trials at Parexel International in Waltham, Massachusetts, USA.[6] She continued to hold other positions such as Clinical Data Manager for Addiction (Opioid Dependence and Alcohol Dependence) at Alkermes 2003 to 2005 and proceeded to Cardiovascular Interventions (Coronary Stents) at Boston Scientific Corporation from and 2005 to 2007.[7]

For a year, she served as a Senior Clinical Data Manager (Consultant) for Oncology (Bone Sarcomas) Clinical Trials at ARIAD Pharmaceuticals, Inc. Continuing to the Premier Research Group, where she was Senior Data Manager for Johnson & Johnson Medical's orthopedics (spine) clinical trials between June 2008 and May 2009.[8]

She further served as a Senior Data Manager between 2009 and 2011 in Epidemiological Studies (Health/Bone Surveys) at the New England Research Institutes, Inc. Her career followed a similar trajectory after her graduate programme in project management, as she was Project Manager (Data Management) for Cardiovascular Interventions (Coronary Stents) Clinical Trials at Abbott Vascular, and Project Manager (Consultant) for Oncology (Leukemia) Clinical Trials at Infinity Pharmaceuticals for six months each, from January to December, 2011.

National Schools Inspectorate Authority

In 2019, Hilda was appointed by President Nana Akufo-Addo to head the National Inspectorate Board, under Ghana's Ministry of Education. Under the Education Regulatory Bodies Act (Act 1023, Part 4), the National Inspectorate Board was renamed to National Schools Inspectorate Authority (NaSIA).

This instituted a new title Inspector-General of Schools. The National Schools Inspectorate Authority (NaSIA) licenses and inspects all pre-tertiary public and private schools in Ghana.[9][10][11][12][13][14][15][16][17]

Publications

  • Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase[18]
  • Chapter in Mann's Pharmacovigilance[19]
  • Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: A modified cohort event monitoring study in public health facilities in Ghana and Uganda[20]
  • The contribution of Ghanaian patients to the reporting of adverse drug reactions[21]
  • Organizational capacities of national pharmacovigilance centres in Africa[22]
  • Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)[23]

References

  1. ^ a b Time with Dr Haggar Hilda Ampadu | Breakfast Daily, 12 June 2021, retrieved 2021-09-01
  2. ^ "Women in Policy Series features NaSIA Executive Director, Haggar Hilda Ampadu - MyJoyOnline.com". www.myjoyonline.com. 11 March 2021. Retrieved 2021-09-06.
  3. ^ a b Segbefia, Sedem (2021-04-24). "Dr. Haggar Hilda Ampadu – holding educational institutions to standards across the board". The Business & Financial Times. Retrieved 2021-09-07.
  4. ^ "Haggar Hilda Ampadu". Pharmaceutical Policy. Retrieved 2021-09-06.
  5. ^ "H Hilda Ampadu". PubFacts. Retrieved 2021-09-06.
  6. ^ "Haggar Hilda Ampadu | ISOP". isoponline.org. Retrieved 2021-09-06.
  7. ^ Online, Peace FM. "NaSIA Is Ensuring Compliance Of COVID-19 Protocols In All Schools – Dr. Ampadu". Peacefmonline.com - Ghana news. Retrieved 2021-09-03.
  8. ^ "Inspectors currently in Akosombo to evaluate Covid-19 outbreak in private schools - Dr Ampadu - MyJoyOnline.com". www.myjoyonline.com. 5 February 2021. Retrieved 2021-09-03.
  9. ^ Segbefia, Sedem (2021-05-18). "Gov't has two-pronged approach to making public schools competitive - NaSIA boss". The Business & Financial Times. Retrieved 2021-09-03.
  10. ^ Online, Peace FM. "Women In Policy Series Featuring National Schools Inspectorate Authority Executive Director". Peacefmonline.com - Ghana news. Retrieved 2021-09-03.
  11. ^ "Women in Policy Series featuring National Schools Inspectorate Authority Executive Director". Happy Ghana. 2021-03-11. Retrieved 2021-09-03.
  12. ^ Segbefia, Sedem (2021-05-21). "National Schools Inspectorate Authority (NaSIA) is changing the story of educational standards". The Business & Financial Times. Retrieved 2021-09-03.
  13. ^ Segbefia, Sedem (2021-04-28). "Schools inspection up 1,500% in one year - NaSIA". The Business & Financial Times. Retrieved 2021-09-03.
  14. ^ "Women in Policy Series features NaSIA Executive Director, Haggar Hilda Ampadu - MyJoyOnline.com". www.myjoyonline.com. 11 March 2021. Retrieved 2021-09-03.
  15. ^ "Women in Policy Series featuring Executive Director of National Schools Inspectorate Authority". GhanaWeb. 2021-03-11. Retrieved 2021-09-03.
  16. ^ "Women in Policy Series featuring National Schools Inspectorate Authority Executive Director". e.TVGhana. 2021-03-11. Retrieved 2021-09-03.
  17. ^ Face to Face with Dr Haggar Hilda Ampadu | Citi Tube, 30 April 2020, retrieved 2021-09-06
  18. ^ "Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®". ResearchGate.
  19. ^ "Mann's Pharmacovigilance". ResearchGate.
  20. ^ "Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: A modified cohort event monitoring study in public health facilities in Ghana and Uganda". ResearchGate.
  21. ^ "The contribution of Ghanaian patients to the reporting of adverse drug reactions: A quantitative and qualitative study". ResearchGate.
  22. ^ "Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences". ResearchGate.
  23. ^ "Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)". ResearchGate.